Related Experiment Video
Updated: Jun 23, 2026

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
Beyond Random Splits: Assessing the Generalization of Graph and Vector Models for WT-Structure-Only Drug Resistance
Zongrui Cheng1, Haoxin Wu1, Dengming Ming1
1College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China.
Abstract:
Background: Predicting mutation-induced changes in binding free energy (ΔΔG) is important for understanding drug resistance and prioritizing resistant variants, yet real-world generalization remains unclear. In clinical diagnosis and early-stage drug screening, mutant complex structures are often unavailable. However, many existing methods rely on paired wild-type (WT) and mutant structures and are evaluated under random splits that may permit substantial protein-level train-test overlap. Methods: We established a WT-complex-structure-only setting, in which mutant structural coordinates are unavailable but mutation annotations are provided, and conducted a controlled comparison of graph- and vector-based configurations under both random and strict UniProt-based splits. We further analyzed graph context, message passing, representation bias, and dataset noise to identify factors limiting protein-disjoint generalization. Results: On MdrDB, random splits yielded apparently moderate performance (Pearson R ≈ 0.55), whereas strict UniProt-based evaluation simulating unseen proteins led to a marked drop (Pearson R ≈ 0.15), indicating that random splits substantially overestimate generalization. Graph-based modeling retained a weak but nonzero signal relative to the vector baseline, although the differences were limited and not statistically significant. Ablation analyses suggested that full-protein structural context was more useful than local pocket-plus-mutation context, whereas full-protein message passing did not provide a clear additional advantage. ΔESM representations reduced protein-background clustering, but overall strict-split performance remained low. Conclusions: WT-only prediction of mutation-induced drug resistance from static structures remains far from solved under realistic protein-disjoint evaluation. Experimental label inconsistency, sparse protein coverage, and missing dynamic structural information may further limit performance, underscoring the need for split-aware evaluation protocols and stronger physical priors.
Related Concept Videos
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Survival Tree
Building a Survival Tree
Constructing a survival tree begins...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...